Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Rushnet Inc RSHN

RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.


PINL:RSHN - Post by User

<< Previous
Bullboard Posts
Next >>
Post by AveragePennyon Sep 28, 2021 8:59am
75 Views
Post# 33929615

RushNet Announce Major Roadmap Spanning 15 Months

RushNet Announce Major Roadmap Spanning 15 Months

Over the last 6 months, RushNet, Inc. has made a major transformational advance. Its controlling interest was purchased by Mr. Ashley Sweat. Since then, RushNet acquired heliosDX, a fast-growing diagnostics laboratory, which is trending $6,000,000 in annual revenue for 2021. Most recently, Grandeza Healthcare was also acquired by RushNet, which is trending over $1,600,000 in annual revenue.

Mr. Sweat says, "the last 6 months have been extremely arduous for the company, me personally, and shareholders alike, but extremely rewarding. From the start, the goal has been and continues to be, to bring as much value to RushNet as possible. In doing so, we introduced plans which were repeatedly modified to conform to the ever-changing dynamics of this unique set of business opportunities. The roadmap below, clearly defines the next 15 months, and the intentions of the Company. We will move forward methodically and decisively, as we execute our roadmap for the benefit of the shareholders, as we encounter opportunities." Note that the multiplicity of fundraising initiatives are designed to conform with enhanced revenues and enhance market capitalization to thus lessen the advent of any attendant dilution, albeit anti-dilutive in nature.

https://www.accesswire.com/665867/RushNet-Inc-RSHN-its-Subsidiaries-heliosDX-and-Grandeza-Healthcare-Announce-Major-Roadmap-Spanning-15-Months

<< Previous
Bullboard Posts
Next >>